GEORGE TOWN: Agilent Technologies Inc is working with the Ministry of Science, TECHNOLOGY [] and Innovation's (MOSTI) Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPHARM) to jointly develop biotechnology.
The strategic alliance will involve the setting up of a IPHARM-Agilent Global Reference Research Lab and focus on developing human capital in the emerging field of biotechnology.
The lab will develop global halal testing standards in pharmaceuticals and nutraceuticals, according to the terms of the memorandum of understanding (MoU) signed recently.
It also will provide access to state-of-the-art analytical tools and expertise to develop the local industry and small and medium enterprise (SME) ecosystem in their commercialisation efforts.
Agilent said IPHARM will bring its domain expertise in bioactive compounds research and analysis to the partnership while leveraging Malaysia's inherited strength in biodiversity and its aspiration to be a global Halal testing leader in pharmaceuticals and nutraceuticals.
As a leading provider of bioanalytical instruments and the world's premier company in electronic measurement, Agilent will provide specialised technical expertise to set up the lab and leading-edge analytical and application solutions to jointly develop the global halal testing standards with IPHARM.
Agilent will also transfer its deep base of biotechnology knowledge to Malaysia to build and develop indigenous capabilities through an ecosystem of local knowledge partners.
Agilent Technologies Malaysia/Singapore president Gooi Soon Chai said Agilent shared a common desire with the government to realise the national agenda for biotechnology.
He said the partnership presented an enormous potential to accelerate the development of this field as the next engine of growth for the country.
With the collaboration with Agilent, the Global Reference Research Lab will help intensify IPHARM's research activities in pharmaceuticals and nutraceuticals.
Agilent Technologies, formerly part of Hewlett-Packard, began operations in Penang, Malaysia, in 1972. Today, Agilent has a a 42-acre plant in Bayan Lepas and employs 3,000 workers.
The strategic alliance will involve the setting up of a IPHARM-Agilent Global Reference Research Lab and focus on developing human capital in the emerging field of biotechnology.
The lab will develop global halal testing standards in pharmaceuticals and nutraceuticals, according to the terms of the memorandum of understanding (MoU) signed recently.
It also will provide access to state-of-the-art analytical tools and expertise to develop the local industry and small and medium enterprise (SME) ecosystem in their commercialisation efforts.
Agilent said IPHARM will bring its domain expertise in bioactive compounds research and analysis to the partnership while leveraging Malaysia's inherited strength in biodiversity and its aspiration to be a global Halal testing leader in pharmaceuticals and nutraceuticals.
As a leading provider of bioanalytical instruments and the world's premier company in electronic measurement, Agilent will provide specialised technical expertise to set up the lab and leading-edge analytical and application solutions to jointly develop the global halal testing standards with IPHARM.
Agilent will also transfer its deep base of biotechnology knowledge to Malaysia to build and develop indigenous capabilities through an ecosystem of local knowledge partners.
Agilent Technologies Malaysia/Singapore president Gooi Soon Chai said Agilent shared a common desire with the government to realise the national agenda for biotechnology.
He said the partnership presented an enormous potential to accelerate the development of this field as the next engine of growth for the country.
With the collaboration with Agilent, the Global Reference Research Lab will help intensify IPHARM's research activities in pharmaceuticals and nutraceuticals.
Agilent Technologies, formerly part of Hewlett-Packard, began operations in Penang, Malaysia, in 1972. Today, Agilent has a a 42-acre plant in Bayan Lepas and employs 3,000 workers.
No comments:
Post a Comment